paclitaxel has been researched along with Medulloblastoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brem, H; Cahan, MA; Colvin, OM; Walter, KA | 1 |
| Gannett, DE; Hamilton, AJ; Hill, D; Stea, B | 1 |
| Berger, MS; Bobola, MS; Silber, JR; Tseng, SH | 1 |
3 other study(ies) available for paclitaxel and Medulloblastoma
| Article | Year |
|---|---|
Cytotoxicity of taxol in vitro against human and rat malignant brain tumors.
Topics: Animals; Brain Neoplasms; Cerebellar Neoplasms; Glioma; Humans; Medulloblastoma; Paclitaxel; Rats; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1994 |
Paclitaxel as a radiosensitizer combined with fractionated stereotactic radiotherapy in the treatment of recurrent medulloblastoma.
Topics: Adult; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Humans; Magnetic Resonance Imaging; Male; Medulloblastoma; Neoplasm Recurrence, Local; Paclitaxel; Palliative Care; Quality of Life; Radiation-Sensitizing Agents; Radiosurgery; Radiotherapy Dosage | 1997 |
Characterization of paclitaxel (Taxol) sensitivity in human glioma- and medulloblastoma-derived cell lines.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Astrocytoma; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain Neoplasms; Calcium Channel Blockers; Cell Cycle; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Medulloblastoma; Microtubules; Neoplasm Proteins; Paclitaxel; Tumor Cells, Cultured | 1999 |